Shire seeks AbbVie bid of close to 53 pounds per share: sources
NEW YORK (Reuters) - Shire Plc is seeking a higher takeover offer from U.S. drugmaker AbbVie Inc that would value the company at about 31 billion pounds ($53 billion), according...
All Stories
Credit Suisse names vice chairman of healthcare group: memo
(Reuters) - Credit Suisse AG has named senior banker Tom Davidson vice chairman of its global healthcare group, according to a memo released to employees on Wednesday. Davidson will focus...
Exclusive: Merck explores $15 billion-plus drug portfolio sale
NEW YORK/LONDON (Reuters) - Merck & Co Inc is considering selling a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the...
Exclusive: Allergan approached Shire about takeover but rebuffed -sources
NEW YORK (Reuters) - Allergan Inc approached Shire Plc in recent months about a possible takeover but was rebuffed, according to people familiar with the matter, in the latest example...
Exclusive: Allergan approached Shire about takeover but rebuffed -sources
NEW YORK (Reuters) - Allergan Inc approached Shire Plc in recent months about a possible takeover but was rebuffed, according to people familiar with the matter, in the latest example...
Exclusive: Surgical device maker ConMed Corp explores sale of company – sources
(Reuters) - ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout...
Yodle selects Credit Suisse, Deutsche Bank for IPO: sources
NEW YORK (Reuters) - Marketing software company Yodle has selected banks for an initial public offering that is expected to come later this year and could raise $100 million, according...
Baxter explores sale of its vaccines business -sources
NEW YORK/FRANKFURT (Reuters) - Baxter International Inc is exploring a sale of its vaccines business, according to people familiar with the matter, the latest healthcare company to look at divesting...
Baxter explores sale of its vaccines business -sources
NEW YORK/FRANKFURT (Reuters) - Baxter International Inc is exploring a sale of its vaccines business, according to people familiar with the matter, the latest healthcare company to look at divesting...
Activist investors bump into each other in campaigns
NEW YORK, March 17 (Reuters) - When Barington Capital Group in October reported a stake of more than 2 percent in Darden Restaurants Inc with a vow to shake up...